Sociodemographic and clinical characteristics of patients with Kaposi sarcoma: Characterization of early-onset disease in a serial cross-sectional Study, 2010-2022

Figure 1 A/B. Sankey Diagrams Illustrating Treatment Pathways and Clinical Characteristics in Kaposi sarcoma (KS). (A, left) KS subgroups (Classic KS, Early-Onset KS, and HIV-associated KS by CD4 strata) and the treatment modalities they received. (B, right) Treatment modalities (None, Chemotherapy, Local Therapy, ART Only, Stop Immunosuppressant) and their association with clinical outcomes (Progression, Stable, Resolution). Treatment options with less than 5 counts not included in the sankeyplot.图1 A/B：呈现卡波西肉瘤（Kaposi sarcoma, KS）治疗路径与临床特征的桑基图（Sankey Diagrams）。（左图A）卡波西肉瘤亚组（经典型卡波西肉瘤、早发性卡波西肉瘤以及按CD4细胞分层的HIV相关卡波西肉瘤）及其接受的治疗方式。（右图B）各类治疗方式（无治疗、化疗、局部治疗、仅抗反转录病毒治疗（Antiretroviral Therapy, ART）、停用免疫抑制剂）及其与临床结局（疾病进展、病情稳定、病灶缓解）的关联。样本量少于5例的治疗方案未被纳入本次桑基图绘制。